Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: nationwide data from the SMART Programme.
Jean SS, Hsueh PR, Lee WS, Chang HT, Chou MY, Chen IS, Wang JH, Lin CF, Shyr JM, Ko WC, Wu JJ, Liu YC, Huang WK, Teng LJ, Liu CY. Jean SS, et al. Eur J Clin Microbiol Infect Dis. 2010 Apr;29(4):471-5. doi: 10.1007/s10096-009-0866-6. Epub 2010 Jan 27. Eur J Clin Microbiol Infect Dis. 2010. PMID: 20108018
Distributions of plasmidic genes encoding extended-spectrum and AmpC β-lactamases, and susceptibilities of global non-carbapenemase-producing meropenem-resistant Enterobacterales to ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam-avibactam, 2017-2022.
Jean SS, Chang HT, Huang CL, Liu IM, Hsieh PC, Hsueh PR. Jean SS, et al. J Infect. 2024 Dec 30;90(2):106380. doi: 10.1016/j.jinf.2024.106380. Online ahead of print. J Infect. 2024. PMID: 39742976 Free article. No abstract available.
Geographic differences in susceptibility profiles of potential non-class B carbapenemase-producing Enterobacterales isolates against ceftazidime-avibactam, meropenem-vaborbactam, colistin, amikacin, gentamicin, and tigecycline: Data from the Antimicrobial Testing Leadership and Surveillance, 2018-2022.
Jean SS, Ko WC, Liu IM, Hsieh PC, Hsueh PR. Jean SS, et al. Int J Antimicrob Agents. 2024 Dec;64(6):107363. doi: 10.1016/j.ijantimicag.2024.107363. Epub 2024 Oct 24. Int J Antimicrob Agents. 2024. PMID: 39455015
91 results